Julie Tandonnet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julie Tandonnet has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Arnault Tauziède-Espariat
Department of Neuropathology, GHU Paris - Psychiatry and Neuroscience, Sainte-Anne Hospital, Paris, France
1 shared publication Arthur Durouchoux
Department of Neurosurgery University Hospital of Bordeaux Bordeaux France
1 shared publicationCéline Khouri
Department of Pediatric and Adolescent Oncology, Gustave-Roussy, Université Paris-Saclay, Villejuif, France
1 shared publication- Daniel Orbach
SIREDO Oncology Centre (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France
1 shared publication - Dorian Bochaton
Department of Neuropathology, GHU Paris ‐ Psychiatry and Neuroscience Sainte‐Anne Hospital Paris France
1 shared publication Emmanuelle Gardiest
Department of Pediatric Oncology, Toulouse University Hospital, Toulouse 31300, France
1 shared publication
Latest Publications
- Open Access
- 4 October 2026
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 52 (5)
A Case of Primary Intramedullary Infantile Fibrosarcoma With an RBPMS::NTRK3 Fusion and Response to Larotrectinib
Summary: First reported case of primary central nervous system infantile fibrosarcoma. Expansion of the molecular spectrum of infantile fibrosarcoma with identification of an RBPMS::NTRK3 fusion. Marked efficacy of larotrectinib observed in an unresectable CNS tumour. Reinforces the importance of molecular testing in atypical paediatric CNS tumours.
- 4 October 2026
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 52 (5)
Open AccessA Case of Primary Intramedullary Infantile Fibrosarcoma With an RBPMS::NTRK3 Fusion and Response to Larotrectinib
Summary: First reported case of primary central nervous system infantile fibrosarcoma. Expansion of the molecular spectrum of infantile fibrosarcoma with identification of an RBPMS::NTRK3 fusion. Marked efficacy of larotrectinib observed in an unresectable CNS tumour. Reinforces the importance of molecular testing in atypical paediatric CNS tumours.
- 21 June 2026
- Published by Elsevier in European Journal of Cancer
- Vol. 244, 116904
Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience
- 21 June 2026
- Published by Elsevier in European Journal of Cancer
- Vol. 244, 116904
Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience